Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Onureg

(ON-yoo-reg)
A drug that contains the active ingredient azacitidine and is used to treat adults with certain types of acute myeloid leukemia. It is used in patients whose cancer is in first complete remission after intensive induction chemotherapy and who were not able to finish intensive therapy that would cure their cancer. Onureg stops cells from making DNA and may kill cancer cells. It is a type of antimetabolite.
Search NCI's Dictionary of Cancer Terms